The Tribune

FREEPORT, GRAND BAHAMA (PRWEB) – Okyanos, considered to be the leader in cell therapy, announced the addition of Dr Jeffrey Hartog to its medical team to accommodate the growing demand for adult stem cell treatment.

Dr Hartog, a recognised expert in the field of cell-assisted cosmetic and reconstructive surgery, brings considerable experience to Okyanos. With over 10,000 surgical procedures performed and over 20 years of practice, Dr Hartog performed his first cell-assisted breast reconstruction in 2010, putting him at the forefront of cell therapy as the next phase in the evolution of medicine.

In addition to dual board certification in plastic surgery and oral and maxillofacial Surgery, Dr Hartog’s diverse medical background includes residencies in four different specialities: plastic and reconstructive surgery at the University of Utah in Salt Lake City, Utah; general surgery at Baylor University in Dallas, Texas; oral and maxillofacial surgery as well as anaesthesiology at the University of Miami.

His duties at Okyanos will include oversight of the critical water-assisted liposuction (WAL) step of the cell therapy process as well as the systemic administration of patients’ own stem cells. WAL is an advanced form of fat harvesting that produces higher quantities of stem and regenerative cells in a minimally traumatic way.

“Dr Hartog is warmly welcomed to the Okyanos team,” said CEO Matthew Feshbach. “We are very pleased to have such a dedicated, uniquely qualified surgeon working with us to help our patients achieve a more normal life with cell therapy.”

Dr Hartog also heads the only plastic surgery clinic in the US to have immediate access to an FDA-registered tissue bank to store fat removed with liposuction for fat transfer procedures and maintains medical staff privileges at the Orlando Regional Medical System in Orlando, Florida, and the Aesthetic Surgery Center of Winter Park in Winter Park, as well as professional memberships with the American Society for Aesthetic Plastic Surgery, American Society of Plastic Surgeons, International Society of Plastic Regenerative Surgeons and International Federation for Adipose Therapeutics and Science.

“I am honoured to join Okyanos as they lead the way in this new category of personalised healthcare,” said Dr Hartog. “As a physician, I am excited at what the future holds for so many patients who have exhausted all the medical options currently available to them.”

Adult stem cell therapy has emerged as a new treatment alternative for those who are restricted in activities they can no longer do but are determined to live a more normal life.

Based in Freeport, Okyanos’ cell therapy is available to patients suffering with the daily limitations of heart disease, neuropathy, diabetes, multiple sclerosis, arthritis, orthopaedic problems and other chronic, degenerative conditions. The procedure is premised on the healing power of adult stem cells isolated from the patient’s body fat which have the ability to decrease inflammation, repair damaged tissue, facilitate better cell-to-cell communication and stimulate new blood vessel growth.